Picked By James (Not rated yet) on Stock Picks
This Biotech Stock has potential as it has the ICT-107 product which is currently in a Phase II study and is a vaccine used in the treatment of glioblastoma multiforme (GBM). The company already successfully completed its Phase I trial, which showed prolonged survival with little to no side effects.
Picked By admin (Accuracy:25%) on Stock Picks
Yahoo has a P/E ratio of 7.8, below the S&P 500 P/E ratio of 17.7. Shares are up 30.1% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Yahoo a buy, 1 analyst rates it a sell, and 13 rate it a hold.
Picked By admin (Accuracy:25%) on Stock Picks
My analysis - blab,blah
Target Price: $25.50
Time Frame: 6 months
Picked By admin (Accuracy:25%) on Stock Picks
Going downnnnnnnnnnn
Target Price: $4.50
Time Frame: 1 months
Picked By admin (Accuracy:25%) on Stock Picks
An online community for stock investor/traders where crowd wisdom is used to pick stocks
Target Price: $50.00
Time Frame: 1 months
